BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Bio Essence Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.42+0.03 (+7.72%)
Close on Oct 19, 2026
- Market cap
- $21.38M
- P/E (TTM)
- 10.5
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Bio Essence has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Bio Essence filed with the SEC
CONSENT RESOLUTION OF THE BOARD OF DIRECTORS
Executive or director change · Other events · EX-99.1 to Form 8-K
Bio Essence Corp. (the “ Company ”)
Executive or director change · Other events · EX-99.2 to Form 8-K
CONSENT OF BOARD OF DIRECTORS (AND EXHIBIT)
Other events · EX-99.1 to Form 8-K